Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2 is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.610. It has been cited 18 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0.168
From 10 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institute on Aging
Grant: R21 AG065896-01A1
National Institutes of Health
Grant: 1RF1AG069483-01A1
Genetic analysis of UBQLN2-associated neurodegeneration in frontotemporal dementia
National Cancer Institute
Grant: 1R21 NS101661-01-A1
ALS Association
Grant: Proteostatic regulation by Ubiquilins in ALS
NINDS NIH HHS
Grant: R21 NS101661
NIA NIH HHS
Grant: R21 AG065896
NIA NIH HHS
Grant: RF1 AG069483
NIGMS NIH HHS
Grant: R35 GM126914
National Institutes of Health
Grant: 1R21AG065896-01A1
Pathway discovery for ubiquilin-associated ALS/Dementia
National Institutes of Health
Grant: 5R21NS101661-02
Drosophila models for ubiquilin-associated ALS
FWCI
3.01
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords